N-isobutyroyl-5’-N-Boc-L-Lys(OMe)guanosine | 1453185-73-3

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: N-isobutyroyl-5’-N-Boc-L-Lys(OMe)guanosine
• CAS: 1453185-73-3
• 化学式: C₂₆H₃₉N₇O₁₀
• 分子量: 609.637
• InChiKey: OLBSCYCBUFWYBT-DUHRUEGVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.31
• 重原子数：
  43.0
• 可旋转键数：
  11.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  236.09
• 氢给体数：
  6.0
• 氢受体数：
  13.0

反应信息

• 作为反应物：
  描述：

  N-isobutyroyl-5’-N-Boc-L-Lys(OMe)guanosine 、 棕榈酰氯 在 吡啶 作用下， 反应 2.0h， 以99%的产率得到N-isobutyroyl-5’-N-Boc-L-Lys(OMe)-2’,3’-di-O-(palmitoyl)guanosine
  参考文献：
  名称：

  Synthesis, DNA binding and anti-leukemic activity of an aminoacyl nucleolipid

  摘要：

  The synthesis and characterization of a new class of DNA binding molecule exhibiting potent and selective anti-leukemic activity is described. The synthesis of an aminoacyl nucleolipid was developed from an efficient EEDQ coupling strategy, in which a series of seven bioconjugates were synthesized in yields of 53-78%. Guanosine bioconjugate 7, was used as building block for the synthesis of a target aminoacyl nucleolipid 14. Its GRP78 DNA binding affinity was confirmed by gel shift assay, CD spectroscopy, T-m measurements and dynamic light scattering experiments. Moreover, in a single dose (10 mu M) screen against a panel of 60 cancer cell lines, aminoacyl nucleolipid 14 was found to selectively trigger greater than 90% cell death in a SR human leukemia cancer cell line. The reported aminoacyl nucleolipid represents a useful model for a new class of DNA binding molecules for the development of potent and selective anti-cancer agents. Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2013.07.030
• 作为产物：
  描述：

  N-isobutyroyl-5’-N-Boc-L-Lys(OMe)-2’,3’-di-O-(carbobenzyloxy)guanosine 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 为溶剂， 反应 1.5h， 以99%的产率得到N-isobutyroyl-5’-N-Boc-L-Lys(OMe)guanosine
  参考文献：
  名称：

  Synthesis, DNA binding and anti-leukemic activity of an aminoacyl nucleolipid

  摘要：

  The synthesis and characterization of a new class of DNA binding molecule exhibiting potent and selective anti-leukemic activity is described. The synthesis of an aminoacyl nucleolipid was developed from an efficient EEDQ coupling strategy, in which a series of seven bioconjugates were synthesized in yields of 53-78%. Guanosine bioconjugate 7, was used as building block for the synthesis of a target aminoacyl nucleolipid 14. Its GRP78 DNA binding affinity was confirmed by gel shift assay, CD spectroscopy, T-m measurements and dynamic light scattering experiments. Moreover, in a single dose (10 mu M) screen against a panel of 60 cancer cell lines, aminoacyl nucleolipid 14 was found to selectively trigger greater than 90% cell death in a SR human leukemia cancer cell line. The reported aminoacyl nucleolipid represents a useful model for a new class of DNA binding molecules for the development of potent and selective anti-cancer agents. Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2013.07.030